Innovative use of self-expanded polytetrafluoroethylene endoprosthesis for percutaneous endovascular interventions.

MedStar author(s):
Citation: Catheterization & Cardiovascular Interventions. 81(4):719-26, 2013 Mar.PMID: 23044717Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Case Reports | Journal ArticleSubject headings: *Blood Vessel Prosthesis | *Blood Vessel Prosthesis Implantation/is [Instrumentation] | *Endovascular Procedures/is [Instrumentation] | *Polytetrafluoroethylene | *Stents | *Vascular Diseases/th [Therapy] | Aged | Aged, 80 and over | Aneurysm/th [Therapy] | Arteriovenous Fistula/th [Therapy] | Coronary Artery Bypass/ae [Adverse Effects] | Female | Femoral Artery/in [Injuries] | Femoral Artery/ra [Radiography] | Femoral Artery/us [Ultrasonography] | Femoral Vein/ra [Radiography] | Humans | Male | Middle Aged | Prosthesis Design | Saphenous Vein/ra [Radiography] | Saphenous Vein/tr [Transplantation] | Tomography, X-Ray Computed | Treatment Outcome | Ultrasonography, Doppler, Color | Ultrasonography, Interventional | Vascular Diseases/di [Diagnosis] | Vascular Diseases/et [Etiology] | Vascular System Injuries/th [Therapy]Year: 2013Local holdings: Available online from MWHC library: 1996 - present, Available in print through MWHC library: 1996 - 2006ISSN:
  • 1522-1946
Name of journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & InterventionsAbstract: VIABAHN endoprosthesis (Gore & Associates, Flagstaff, AZ), a nitinol self-expanding polytetrafluoroethylene (PTFE) lined stent, has demonstrated utility for percutaneous treatment of chronic occlusive disease involving the superficial femoral artery. In a case series communication we aimed to describe the feasibility of a PTFE-lined stent for percutaneous treatment of conditions other than chronic occlusive disease. We report the successful use of PTFE-endoprosthesis to percutaneously treat several vascular conditions, including arterio-venous fistula closure, reconstruction of a distal limb of an aorto-femoral endoprosthesis aneurysm, femoral artery perforation repair, and an exclusion of large saphenous vein graft aorto-coronary bypass aneurysm. This case series illustrates the feasibility of the "off-label" use of self-expanded PTFE endoprosthesis to percutaneously treat several conditions, which would otherwise require "open" surgical reconstructions. Copyright 2011 Wiley Periodicals, Inc.All authors: Bernardo NL, Maluenda G, Waksman RFiscal year: FY2013Digital Object Identifier: Date added to catalog: 2013-09-17
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 23044717 Available 23044717

Available online from MWHC library: 1996 - present, Available in print through MWHC library: 1996 - 2006

VIABAHN endoprosthesis (Gore & Associates, Flagstaff, AZ), a nitinol self-expanding polytetrafluoroethylene (PTFE) lined stent, has demonstrated utility for percutaneous treatment of chronic occlusive disease involving the superficial femoral artery. In a case series communication we aimed to describe the feasibility of a PTFE-lined stent for percutaneous treatment of conditions other than chronic occlusive disease. We report the successful use of PTFE-endoprosthesis to percutaneously treat several vascular conditions, including arterio-venous fistula closure, reconstruction of a distal limb of an aorto-femoral endoprosthesis aneurysm, femoral artery perforation repair, and an exclusion of large saphenous vein graft aorto-coronary bypass aneurysm. This case series illustrates the feasibility of the "off-label" use of self-expanded PTFE endoprosthesis to percutaneously treat several conditions, which would otherwise require "open" surgical reconstructions. Copyright 2011 Wiley Periodicals, Inc.

English

Powered by Koha